Re-appointment of Mr. S Muralidharan as Non-Executive Independent Director w.e.f 29 June 2026.
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amrutanjan Health Care Limited announced two board changes at its 8 May 2026 board meeting. First, it appointed Mr. Ramaswami Krishnan (DIN: 08562199) as an Additional Director designated as Non-Executive Independent Director for a 5-year term from 8 May 2026 to 7 May 2031, subject to shareholder approval. Mr. Krishnan is a qualified CA, CS, and CWA with a Ph.D. and MBA, previously associated with Malladi Drugs and Pharmaceuticals Limited. Second, the company reappointed Mr. Muralidharan Swayambunathan (DIN: 09198315) as Non-Executive Independent Director for a second and final term of 5 years from 29 June 2026 to 28 June 2031, also subject to shareholder approval. Mr. Swayambunathan has 37+ years of experience across industries in India and abroad, including roles at TVS Sundaram and international operations in Dubai.
Both changes are routine governance updates that strengthen the board's independence. The appointment of an experienced finance professional and the re-appointment of a seasoned independent director are positive for corporate governance. No immediate impact on stock price expected as both are subject to shareholder approval.